Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.840
+0.010 (0.21%)
At close: Apr 28, 2026, 4:00 PM EDT
4.793
-0.047 (-0.98%)
After-hours: Apr 28, 2026, 7:35 PM EDT
Myriad Genetics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Myriad Genetics stock have an average target of 7.64, with a low estimate of 6.00 and a high estimate of 10. The average target predicts an increase of 57.85% from the current stock price of 4.84.
Analyst Consensus: Buy
* Price targets were last updated on Feb 24, 2026.
Analyst Ratings
The average analyst rating for Myriad Genetics stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 9 | 9 | 9 | 5 | 5 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 9 | 9 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +23.97% | Feb 24, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $6.5 → $6 | Hold | Maintains | $6.5 → $6 | +23.97% | Feb 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $8.5 | Buy | Maintains | $9 → $8.5 | +75.62% | Nov 11, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $6.5 | Hold | Maintains | $6 → $6.5 | +34.30% | Nov 5, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +85.95% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
881.04M
from 824.50M
Increased by 6.86%
Revenue Next Year
929.04M
from 881.04M
Increased by 5.45%
EPS This Year
0.05
from -3.95
EPS Next Year
0.16
from 0.05
Increased by 228.38%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 914.1M | 990.3M | |||
| Avg | 881.0M | 929.0M | |||
| Low | 822.6M | 842.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.9% | 12.4% | |||
| Avg | 6.9% | 5.4% | |||
| Low | -0.2% | -4.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.23 | 0.43 | |||
| Avg | 0.05 | 0.16 | |||
| Low | -0.10 | -0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 806.9% | |||
| Avg | - | 228.4% | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.